We provide you with 20 years of free, institutional-grade data for LIVN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LIVN. Explore the full financial landscape of LIVN stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Bolton Stephanie | Initial | 2024-03-11 | |||
| KOZY WILLIAM A | Sale | -4,871 | $54.81 | $266,980 | 2024-03-04 |
| KOZY WILLIAM A | Derivatives Exercise | 14,512 | 2024-03-04 | ||
| Saia Andrea Lynn | Sale | -314 | $51.74 | $16,246 | 2024-01-03 |
| Saia Andrea Lynn | Derivatives Exercise | 1,468 | 2024-01-03 | ||
| Hutchinson Michael Damon | Sale | -904 | $50.07 | $45,263 | 2023-12-19 |
| Hutchinson Michael Damon | Derivatives Exercise | 2,254 | 2023-12-19 | ||
| Shvartsburg Alex | Sale | -167 | $50.07 | $8,362 | 2023-12-19 |
| Shvartsburg Alex | Derivatives Exercise | 613 | 2023-12-19 | ||
| KOZY WILLIAM A | Sale | -3,729 | $47.94 | $178,768 | 2023-10-17 |
| KOZY WILLIAM A | Derivatives Exercise | 10,311 | 2023-10-17 | ||
| Story Brooke | Sale | -345 | $57.8 | $19,941 | 2023-09-19 |
| Story Brooke | Derivatives Exercise | 1,725 | 2023-09-19 | ||
| Hebbelinck Trui | Sale | -207 | $56.8 | $11,758 | 2023-09-19 |
| Hebbelinck Trui | Derivatives Exercise | 440 | 2023-09-19 | ||
| O'Kane Sharon | Sale | -979 | $48.4 | $47,384 | 2023-06-20 |
| O'Kane Sharon | Derivatives Exercise | 2,082 | 2023-06-20 | ||
| Moore Daniel Jeffrey | Sale | -444 | $48.4 | $21,490 | 2023-06-20 |
| Moore Daniel Jeffrey | Derivatives Exercise | 2,082 | 2023-06-20 | ||
| Enxing Seng Stacy | Sale | -445 | $48.4 | $21,538 | 2023-06-20 |
| Enxing Seng Stacy | Derivatives Exercise | 2,082 | 2023-06-20 | ||
| Bianchi Francesco | Sale | -445 | $48.4 | $21,538 | 2023-06-20 |
| Bianchi Francesco | Derivatives Exercise | 2,082 | 2023-06-20 | ||
| SCHERMERHORN TODD C | Sale | -453 | $48.4 | $21,925 | 2023-06-20 |
| SCHERMERHORN TODD C | Derivatives Exercise | 2,082 | 2023-06-20 | ||
| WILVER PETER M | Sale | -445 | $48.4 | $21,538 | 2023-06-20 |
| WILVER PETER M | Derivatives Exercise | 2,082 | 2023-06-20 | ||
| Saia Andrea Lynn | Sale | -445 | $48.4 | $21,538 | 2023-06-20 |
| Saia Andrea Lynn | Derivatives Exercise | 2,082 | 2023-06-20 | ||
| Shvartsburg Alex | Sale | -742 | $48.4 | $35,913 | 2023-06-20 |
| Shvartsburg Alex | Derivatives Exercise | 1,577 | 2023-06-20 | ||
| KOZY WILLIAM A | Sale | -515 | $48.4 | $24,926 | 2023-06-20 |
| KOZY WILLIAM A | Derivatives Exercise | 3,284 | 2023-06-20 | ||
| McDonald Damien | Sale | -2,220 | $42.55 | $94,461 | 2023-04-28 |
| McDonald Damien | Sale | -10,112 | $42.71 | $431,884 | 2023-04-03 |
| McDonald Damien | Derivatives Exercise | 21,510 | 2023-04-03 | ||
| Hebbelinck Trui | Sale | -1,380 | $42.71 | $58,940 | 2023-04-03 |
| Hebbelinck Trui | Derivatives Exercise | 2,933 | 2023-04-03 | ||
| Shvartsburg Alex | Sale | -1,348 | $42.71 | $57,573 | 2023-04-03 |
| Shvartsburg Alex | Derivatives Exercise | 2,864 | 2023-04-03 | ||
| Dolci Marco | Sale | -1,534 | $42.71 | $65,517 | 2023-04-03 |
| Dolci Marco | Derivatives Exercise | 3,563 | 2023-04-03 | ||
| Dolci Marco | Sale | -2,559 | $47.99 | $122,806 | 2023-03-01 |
| Dolci Marco | Derivatives Exercise | 5,949 | 2023-03-01 | ||
| Hebbelinck Trui | Sale | -2,238 | $47.99 | $107,402 | 2023-03-01 |
| Hebbelinck Trui | Derivatives Exercise | 4,759 | 2023-03-01 | ||
| McDonald Damien | Sale | -16,780 | $47.99 | $805,272 | 2023-03-01 |
| McDonald Damien | Derivatives Exercise | 35,700 | 2023-03-01 | ||
| Shvartsburg Alex | Sale | -289 | $54.37 | $15,713 | 2022-12-19 |
| Shvartsburg Alex | Derivatives Exercise | 613 | 2022-12-19 | ||
| McDonald Damien | Sale | -2,220 | $54.56 | $121,123 | 2022-12-19 |
| Skeffington Keyna Pidcock | Sale | -141 | $56.8 | $8,009 | 2022-09-19 |
| Skeffington Keyna Pidcock | Derivatives Exercise | 300 | 2022-09-19 | ||
| Hebbelinck Trui | Sale | -207 | $56.8 | $11,758 | 2022-09-19 |
| Hebbelinck Trui | Derivatives Exercise | 440 | 2022-09-19 | ||
| Saia Andrea Lynn | Sale | -113 | $59.94 | $6,773 | 2022-06-17 |
| Saia Andrea Lynn | Derivatives Exercise | 1,346 | 2022-06-17 | ||
| Novak Alfred J | Sale | -97 | $59.94 | $5,814 | 2022-06-17 |
| Novak Alfred J | Derivatives Exercise | 1,346 | 2022-06-17 | ||
| Moore Daniel Jeffrey | Sale | -80 | $59.94 | $4,795 | 2022-06-17 |
| Moore Daniel Jeffrey | Derivatives Exercise | 1,346 | 2022-06-17 | ||
| Shvartsburg Alex | Sale | -742 | $59.94 | $44,475 | 2022-06-17 |
| Shvartsburg Alex | Derivatives Exercise | 1,577 | 2022-06-17 | ||
| ROSENTHAL ARTHUR L | Sale | -123 | $59.94 | $7,373 | 2022-06-17 |
| ROSENTHAL ARTHUR L | Derivatives Exercise | 1,346 | 2022-06-17 | ||
| SCHERMERHORN TODD C | Sale | -36 | $59.94 | $2,158 | 2022-06-17 |
| SCHERMERHORN TODD C | Derivatives Exercise | 1,346 | 2022-06-17 | ||
| KOZY WILLIAM A | Sale | -114 | $59.94 | $6,833 | 2022-06-17 |
| KOZY WILLIAM A | Derivatives Exercise | 2,264 | 2022-06-17 | ||
| Enxing Seng Stacy | Sale | -129 | $59.94 | $7,732 | 2022-06-17 |
| Enxing Seng Stacy | Derivatives Exercise | 1,346 | 2022-06-17 | ||
| O'Kane Sharon | Sale | -636 | $59.94 | $38,122 | 2022-06-17 |
| O'Kane Sharon | Derivatives Exercise | 1,346 | 2022-06-17 | ||
| Bianchi Francesco | Sale | -98 | $59.94 | $5,874 | 2022-06-17 |
| Bianchi Francesco | Derivatives Exercise | 1,346 | 2022-06-17 | ||
| Moore Daniel Jeffrey | Sale | -1,000 | $83.42 | $83,416 | 2022-04-05 |
| Skeffington Keyna Pidcock | Sale | -1,347 | $81.5 | $109,781 | 2022-04-01 |
| Skeffington Keyna Pidcock | Derivatives Exercise | 2,865 | 2022-04-01 | ||
| Shvartsburg Alex | Sale | -517 | $81.5 | $42,136 | 2022-04-01 |
| Shvartsburg Alex | Derivatives Exercise | 1,550 | 2022-04-01 | ||
| Dolci Marco | Sale | -1,206 | $81.5 | $98,289 | 2022-04-01 |
| Dolci Marco | Derivatives Exercise | 2,801 | 2022-04-01 | ||
| Hebbelinck Trui | Sale | -1,059 | $81.5 | $86,309 | 2022-04-01 |
| Hebbelinck Trui | Derivatives Exercise | 2,248 | 2022-04-01 | ||
| McDonald Damien | Derivatives Exercise | 16,940 | 2022-03-31 | ||
| McDonald Damien | Sale | -10,748 | $81.5 | $875,962 | 2022-03-31 |
| McDonald Damien | Sale | -1,496 | $72.89 | $109,043 | 2022-03-17 |
| McDonald Damien | Derivatives Exercise | 3,182 | 2022-03-17 | ||
| Skeffington Keyna Pidcock | Sale | -216 | $72.89 | $15,744 | 2022-03-17 |
| Skeffington Keyna Pidcock | Derivatives Exercise | 459 | 2022-03-17 | ||
| Shvartsburg Alex | Sale | -184 | $72.89 | $13,412 | 2022-03-17 |
| Shvartsburg Alex | Derivatives Exercise | 390 | 2022-03-17 | ||
| Dolci Marco | Sale | -240 | $72.89 | $17,494 | 2022-03-17 |
| Dolci Marco | Derivatives Exercise | 558 | 2022-03-17 | ||
| McDonald Damien | Sale | -2,429 | $77.38 | $187,956 | 2022-03-03 |
| McDonald Damien | Derivatives Exercise | 5,167 | 2022-03-03 | ||
| Dolci Marco | Sale | -312 | $77.38 | $24,143 | 2022-03-03 |
| Dolci Marco | Derivatives Exercise | 688 | 2022-03-03 | ||
| Hebbelinck Trui | Sale | -263 | $77.38 | $20,351 | 2022-03-03 |
| Hebbelinck Trui | Derivatives Exercise | 559 | 2022-03-03 | ||
| Moore Daniel Jeffrey | Sale | -1,000 | $80 | $80,000 | 2022-03-03 |
| Skeffington Keyna Pidcock | Sale | -364 | $77.38 | $28,166 | 2022-03-03 |
| Skeffington Keyna Pidcock | Derivatives Exercise | 774 | 2022-03-03 | ||
| Moore Daniel Jeffrey | Sale | -1,000 | $80 | $80,000 | 2022-03-01 |
| Moore Daniel Jeffrey | Sale | -1,000 | $85.93 | $85,934 | 2022-01-05 |
| Shvartsburg Alex | Sale | -601 | $80.39 | $48,314 | 2021-12-17 |
| Shvartsburg Alex | Derivatives Exercise | 1,276 | 2021-12-17 | ||
| SCHERMERHORN TODD C | Derivatives Exercise | 1,024 | 2021-12-17 | ||
| McDonald Damien | Sale | -2,784 | $81.5 | $226,896 | 2021-12-15 |
| Moore Daniel Jeffrey | Sale | -1,000 | $81.73 | $81,734 | 2021-12-03 |
| Novak Alfred J | Sale | -2,981 | $90.77 | $270,573 | 2021-11-12 |
| KOZY WILLIAM A | Open Market Purchase | 1,000 | $90.43 | 2021-11-12 | |
| Moore Daniel Jeffrey | Sale | -1,000 | $85.25 | $85,250 | 2021-11-05 |
| Moore Daniel Jeffrey | Sale | -1,000 | $80 | $80,000 | 2021-10-05 |
| Hebbelinck Trui | Sale | -207 | $84.97 | $17,589 | 2021-09-17 |
| Hebbelinck Trui | Derivatives Exercise | 440 | 2021-09-17 | ||
| Skeffington Keyna Pidcock | Sale | -142 | $84.97 | $12,066 | 2021-09-17 |
| Skeffington Keyna Pidcock | Derivatives Exercise | 301 | 2021-09-17 | ||
| Moore Daniel Jeffrey | Sale | -1,000 | $82.4 | $82,402 | 2021-09-03 |
| Moore Daniel Jeffrey | Sale | -1,000 | $86.39 | $86,389 | 2021-08-04 |
| Bianchi Francesco | Derivatives Exercise | 2,337 | 2021-07-01 | ||
| Moore Daniel Jeffrey | Sale | -1,000 | $84.2 | $84,200 | 2021-07-01 |
| Moore Daniel Jeffrey | Derivatives Exercise | 3,931 | 2021-07-01 | ||
| MORRISON HUGH M | Derivatives Exercise | 2,337 | 2021-07-01 | ||
| Enxing Seng Stacy | Derivatives Exercise | 2,337 | 2021-07-01 | ||
| KOZY WILLIAM A | Derivatives Exercise | 2,337 | 2021-07-01 | ||
| Saia Andrea Lynn | Derivatives Exercise | 2,337 | 2021-07-01 | ||
| ROSENTHAL ARTHUR L | Derivatives Exercise | 2,337 | 2021-07-01 | ||
| O'Kane Sharon | Sale | -1,099 | $85.43 | $93,888 | 2021-07-01 |
| O'Kane Sharon | Derivatives Exercise | 2,337 | 2021-07-01 | ||
| Novak Alfred J | Derivatives Exercise | 2,337 | 2021-07-01 | ||
| Shvartsburg Alex | Sale | -742 | $82.14 | $60,948 | 2021-06-16 |
| Shvartsburg Alex | Derivatives Exercise | 1,577 | 2021-06-16 | ||
| Skeffington Keyna Pidcock | Sale | -539 | $81.79 | $44,085 | 2021-06-15 |
| Skeffington Keyna Pidcock | Derivatives Exercise | 1,146 | 2021-06-15 |
The information provided in this report about LIVN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
LivaNova PLC(NASDAQ:LIVN)Â 
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates in two segments, Cardiovascular (CV) and Neuromodulation (NM). The CV segment develops, produces, and sells cardiopulmonary products, including heart-lung machines, oxygena...
Website: http://www.livanova.com
Founded: 1987
Full Time Employees: 4,000
Sector: Healthcare
Industry: Medical Devices